Celecoxib Capsules
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- SPE2D2-25-R-0021
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical is seeking proposals through solicitation SPE2D2-25-R-0021 for a national contract to supply Celecoxib capsules to multiple federal agencies including the Department of Defense, Veterans Affairs, Indian Health Service, and Bureau of Prisons. The procurement covers six different Celecoxib capsule configurations ranging from 50mg to 400mg in various bottle sizes, with offerors required to hold FDA approval and comply with current Good Manufacturing Practices (cGMP). The solicitation operates under a lowest price technically acceptable (LPTA) evaluation methodology, meaning the contract will be awarded to the responsible offeror whose proposal is technically acceptable and provides the lowest evaluated aggregate price. Distribution must occur through Pharmaceutical Prime Vendors, and offerors must submit comprehensive technical and pricing proposals including manufacturing facility information, therapeutic equivalence documentation, and past performance data. The proposal submission period runs from August 26, 2025, through September 25, 2025.
This opportunity does not utilize any set-aside designations and no incumbent contractors are identified in the available documentation. The total estimated annual quantities across all agencies include 8,047 bottles of 50mg capsules, 15,859 bottles of 100mg (100-count), 48,986 bottles of 100mg (500-count), 10,099 bottles of 200mg (100-count), 91,006 bottles of 200mg (500-count), and 2,479 bottles of 400mg capsules. The contract structure includes a one-year base period with four option years, creating a potential five-year total performance period. The awarded contractor will be responsible for quarterly sales reporting, adherence to specific packaging and labeling requirements, and payment of cost recovery fees. While specific dollar values are not disclosed, the substantial quantities and multi-agency scope suggest a significant procurement opportunity within the pharmaceutical preparation manufacturing sector.
Notice text
Celecoxib Capsules Solicitation SPE2D2-25-R-0021.
Files
| File | Type | Posted |
|---|---|---|
| Celecoxib National Contract Solicitation SPE2D225R0021.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Celecoxib Capsules | Award Notice | |
| This notice | Solicitation | |
| Celecoxib Capsules | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| Epinephrine Injector | Medical Supply Chain | No set-aside | |
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity